Search

Pages

1. • Journal article

   • 

   A MAGE-A4 peptide presented by HLA-A2 is recognized by cytolytic T lymphocytes

   Duffour, Marie-Thérèse[UCL] Chaux, Pascal[UCL] Lurquin, C.hristophe[UCL] Cornelis, Guy[UCL] Boon, Thierry[UCL] van der Bruggen, Pierre[UCL] (1999) European Journal of Immunology — Vol. 29, no. 10, p. 3329-3337 (1999)
2. • Journal article

   • 

   A novel strategy for the identification of antigens that are recognised by bovine MHC class I restricted cytotoxic T cells in a protozoan infection using reverse vaccinology.

   Graham, Simon P Honda, Yoshikazu Pellé, Roger Mwangi, Duncan M Glew, E Jane de Villiers, Etienne P Shah, Trushar Bishop, Richard van der Bruggen, Pierre Nene, Vishvanath Taracha, Evans L N (2007) Immunome Research — Vol. 3, p. 2 (2007)
3. • Journal article

   • 

   MAGE-1 expression threshold for the lysis of melanoma cell lines by a specific cytotoxic T lymphocyte

   Lethé, Bernard van der Bruggen, Pierre[UCL] Brasseur, Francis[UCL] Boon, Thierry[UCL] (1997) Melanoma Research — Vol. 7, p. S83-S88 (1997)
4. • Journal article

   • 

   Correlation between the high expression levels of cancer-germline genes with clinical characteristics in esophageal squamous cell carcinoma.

   Chen, Xinfeng Wang, Liping Yue, Dongli Liu, Jinyan Huang, Lan Yang, Li Cao, Ling Qin, Guohui Li, Anqi Wang, Dan Wang, Meng Qi, Yu Zhang, Bin van der Bruggen, Pierre[UCL] Zhang, Yi (2017) Histology and Histopathology : cellular and molecular biology — Vol. 32, no.8, p. 793-803 (2017)
5. • Speech

   • 

   TCR gene transfer: MHC I and II-restricted MAGE epitopes as melanoma-specific immune targets

   Straetemans, Trudy Broertjes, Marieke Drexhage, Joost Coccoris, Miriam Lambrecht, Bart van der Bruggen, Pierre[UCL] Coulie, Pierre[UCL] Gratama, Jan Willem Willemsen, Ralph Debets, Reno (2008) 16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy — Brugge(Belgium)
6. • Journal article

   • 

   IFN-gamma gene transfer restores HLA-class I expression and MAGE-3 antigen presentation to CTL in HLA-deficient small cell lung cancer.

   Traversari, C Meazza, R Coppolecchia, M Basso, S Verrecchia, A van der Bruggen, Pierre[UCL] Ardizzoni, A Gaggero, A Ferrini, S (1997) Gene Therapy — Vol. 4, no. 10, p. 1029-35 (1997)
7. • Speech

   • 

   Is it possible to correct the impaired function of human tumor-infiltrating T lymphocytes?

   Demotte, Nathalie[UCL] Wieers, Grégoire[UCL] Klyosov, Anatole[UCL] van der Bruggen, Pierre[UCL] (2011) Keystone Symposium — Lake Louise, AB, Canada
8. • Journal article

   • 

   Construction and binding analysis of recombinant single-chain TCR derived from tumor-infiltrating lymphocytes and a cytotoxic T lymphocyte clone directed against MAGE-1.

   Lake, D F Salgaller, M L van der Bruggen, Pierre[UCL] Bernstein, R M Marchalonis, J J (1999) International Immunology — Vol. 11, no. 5, p. 745-51 (1999)
9. • Journal article

   • 

   A MAGE-A1 peptide presented to cytolytic T lymphocytes by both HLA-B35 and HLA-A1 molecules.

   Luiten, Rosalie M[UCL] Demotte, Nathalie[UCL] Tine, John[UCL] van der Bruggen, Pierre[UCL] (2000) Tissue Antigens — Vol. 56, no. 1, p. 77-81 (2000)
10. • Journal article

    • 

    Sequence and Expression Pattern of the Human Mage2 Gene

    De Smet, Charles[UCL] Lurquin, C. van der Bruggen, Pierre[UCL] De Plaen, Etienne[UCL] Brasseur, Francis[UCL] Boon, Thierry[UCL] (1994) Immunogenetics — Vol. 39, no. 2, p. 121-129 (1994)
11. • Journal article

    • 

    A retrogen strategy for presentation of an intracellular tumor antigen as an exogenous antigen by dendritic cells induces potent antitumor T helper and CTL responses

    You, ZY Hester, J Rollins, L Spagnoli, GC van der Bruggen, Pierre[UCL] Chen, SY (2001) Cancer Research — Vol. 61, no. 1, p. 197-205 (2001)
12. • Journal article

    • 

    The CD4+ T-Cell Response of Melanoma Patients to a MAGE-A3 Peptide Vaccine Involves Potential Regulatory T Cells.

    François, Violaine[UCL] Ottaviani, Sabrina[UCL] Renkvist, Nicolina Stockis, Julie[UCL] Schuler, Gerold Thielemans, Kris Colau, Didier Marchand, Marie Boon, Thierry[UCL] Lucas, Sophie[UCL] van der Bruggen, Pierre[UCL] (2009) Cancer Research — Vol. 69, no. 10, p. 4335-45 (2009)
13. • Journal article

    • 

    Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma

    Kruit, WHJ Godelaine, D. van Ojik, HH Brichard, VG. Escudier, B Dorval, T Dréno, B. Patel, P van Baren, Nicolas[UCL] Avril, MF Piperno, S Khammari, A Stas, M. Ritter, G. Lethé, Bernard Brasseur, Francis[UCL] Zhang, Y. van der Bruggen, Pierre[UCL] Boon, Thierry[UCL] Eggermont, AMM Marchand, M. (2005) International Journal of Cancer — Vol. 117, no. 4, p. 596-604 (2005)
14. • Journal article

    • 

    A reversible functional defect of CD8(+) T lymphocytes involving loss of tetramer labeling

    Demotte, Nathalie[UCL] Colau, Didier[UCL] Ottaviani, Sabrina[UCL] Godelaine, D. Van Pel, Aline[UCL] Boon, Thierry[UCL] van der Bruggen, Pierre[UCL] (2002) European Journal of Immunology — Vol. 32, no. 6, p. 1688-1697 (2002)
15. • Journal article

    • 

    Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human V gamma/V delta 2 T cells in tumor immunity

    Fisch, P Meuer, E Pende, D Rothenfusser, S Viale, O Kock, S Ferrone, S Fradelizi, D Klein, G. Moretta, L Rammensee, HG. Boon, Thierry[UCL] Coulie, Pierre[UCL] van der Bruggen, Pierre[UCL] (1997) European Journal of Immunology — Vol. 27, no. 12, p. 3368-79 (1997)
16. • Journal article

    • 

    Human tumor antigens recognized by T lymphocytes

    Boon, Thierry[UCL] van der Bruggen, Pierre[UCL] (1996) The Journal of Experimental Medicine — Vol. 183, no. 3, p. 725-729 (1996)
17. • Journal article

    • 

    A MAGE-1 peptide recognized on HLA-DR15 by CD4(+) T cells.

    Chaux, P Lethé, B Van Snick, Jacques[UCL] Corthals, J Schultz, E S Cambiaso, Cesar[UCL] Boon, Thierry[UCL] van der Bruggen, Pierre[UCL] (2001) European journal of immunology — Vol. 31, no. 6, p. 1910-6 (2001)
18. • Journal article

    • 

    A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma.

    Mandruzzato, S Brasseur, Francis[UCL] Andry, G Boon, Thierry[UCL] van der Bruggen, Pierre[UCL] (1997) The Journal of experimental medicine — Vol. 186, no. 5, p. 785-93 (1997)
19. • Journal article

    • 

    A MAGE-3 peptide presented by HLA-DR1 to CD4(+) T cells that were isolated from a melanoma patient vaccinated with a MAGE-3 protein

    Zhang, Y. Chaux, P Stroobant, Vincent Eggermont, AMM Corthals, J Maillere, B Thielemans, K. Marchand, Marie[UCL] Boon, Thierry[UCL] van der Bruggen, Pierre[UCL] (2003) Journal of Immunology — Vol. 171, no. 1, p. 219-225 (2003)
20. • Journal article

    • 

    Isolation and Characterization of an HLA-DPB1*04

    Yao, Xin Lu, Yong-Chen Parker, Linda L. Li, Yong F. El-Gamil, Mona Black, Mary A. Xu, Hui Feldman, Steven A. van der Bruggen, Pierre[UCL] Rosenberg, Steven A. Robbins, Paul F. (2016) Journal of Immunotherapy — Vol. 39, no.5, p. 191-201 (2016)
21. • Journal article

    • 

    Identification of the Mage-1 Gene-product By Monoclonal and Polyclonal Antibodies

    Chen, YT. Stockert, E. Chen, Y. Garinchesa, P. Rettig, WJ. van der Bruggen, Pierre[UCL] Boon, Thierry[UCL] Old, LJ. (1994) Proceedings of the National academy of sciences of the United States of America — Vol. 91, no. 3, p. 1004-1008 (1994)
22. • Journal article

    • 

    Conserved TCR usage by HLA-Cw*1601-restricted T cell clones recognizing melanoma antigens

    Farina, C. van der Bruggen, Pierre[UCL] Boël, P. Parmiani, G. Sensi, M. (1996) International Immunology — Vol. 8, no. 9, p. 1463-1466 (1996)
23. • Journal article

    • 

    Mitochondrial DNA polymerases from yeast to man: a new family of polymerases.

    Lecrenier, N van der Bruggen, Pierre[UCL] Foury, Françoise[UCL] (1997) Gene — Vol. 185, no. 1, p. 147-52 (1997)
24. • Journal article

    • 

    A MAGE-1 antigenic peptide recognized by human cytolytic T lymphocytes on HLA-A2 tumor cells.

    Ottaviani, Sabrina[UCL] Zhang, Yi Boon, Thierry van der Bruggen, Pierre[UCL] (2005) Cancer Immunology Immunotherapy — Vol. 54, no. 12, p. 1214-20 (2005)
25. • Journal article

    • 

    A MAGE-3 peptide presented by HLA-B44 is also recognized by cytolytic T lymphocytes on HLA-B18

    Bilsborough, Janine[UCL] Panichelli, C Duffour, MT Warnier, G. Lurquin, C. Schultz, ES Thielemans, K. Corthals, J Boon, Thierry[UCL] van der Bruggen, Pierre[UCL] (2002) Tissue Antigens — Vol. 60, no. 1, p. 16-24 (2002)

Pages